Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jinxin Fertility GroupJXFGF 86 Equity-to-Asset is 0.66 as of Dec. 2025, which is 1% below its 10-year median of 0.67. GuruFocus rates JXFGF with a GF Score™ of 86/100 and a GF Value™ of $0.43. The stock has 7 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Jinxin Fertility Group ranks better than 67.39% on this metric.
The historical rank and industry rank for Jinxin Fertility Group's Equity-to-Asset or its related term are showing as below:
JXFGF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.11 Med: 0.67 Max: 0.84
Current: 0.64
During the past 10 years, the highest Equity to Asset Ratio of Jinxin Fertility Group was 0.84. The lowest was 0.11. And the median was 0.67.
JXFGF's Equity-to-Asset is ranked better than 67.39% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 0.49
vs JXFGF: 0.64
Jinxin Fertility Group (OTCPK:JXFGF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Jinxin Fertility Group Equity-to-Asset Related Terms
Jinxin Fertility Group Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Jinxin Fertility Group's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JXFGF vs HCA, THC, EHC: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Jinxin Fertility Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinxin Fertility Group Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Jinxin Fertility Group's Equity-to-Asset falls into.
Jinxin Fertility Group Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Jinxin Fertility Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinxin Fertility Group (JXFGF) has a Equity-to-Asset of 0.66 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Jinxin Fertility Group and its competitors. This is near median its historical median of 0.67. Over the past decade, Jinxin Fertility Group's Equity-to-Asset has ranged from 0.11 to 0.84. According to the industry distribution chart, Jinxin Fertility Group ranks #224 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 32.6%.
Is Jinxin Fertility Group's Equity-to-Asset too high?
Jinxin Fertility Group's current Equity-to-Asset of 0.66 is near median its 10-year median of 0.67. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 0.84. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. Jinxin Fertility Group's value of 0.66 is 34.7% above this industry median. Based on the distribution chart, Jinxin Fertility Group ranks #224 out of 687 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Jinxin Fertility Group has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Jinxin Fertility Group's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jinxin Fertility Group ranks #224 out of 687 companies for Equity-to-Asset. This puts Jinxin Fertility Group in the upper half of its industry. The industry median Equity-to-Asset is 0.49. Jinxin Fertility Group's value of 0.66 is 34.7% above this benchmark. Historically, Jinxin Fertility Group's own Equity-to-Asset has ranged from 0.11 to 0.84 over the past decade. While the company's 10-year median is 0.67 vs. the industry median of 0.49, Jinxin Fertility Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jinxin Fertility Group's current Equity-to-Asset of 0.66 is 34.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Jinxin Fertility Group and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinxin Fertility Group's current Equity-to-Asset is 0.66, which is near median its own 10-year median of 0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinxin Fertility Group stock overvalued right now?
Jinxin Fertility Group (JXFGF) has a current Equity-to-Asset of 0.66. The stock's GF Value™ is $0.43, compared to a current price of $0.29 — trading 32.6% below its estimated fair value. The current Equity-to-Asset is 0.66, which is near median its 10-year median of 0.67 and 34.7% above the Healthcare Providers & Services industry median of 0.49. Jinxin Fertility Group's overall GF Score™ is 86/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Jinxin Fertility Group (JXFGF), the current Equity-to-Asset is 0.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinxin Fertility Group (JXFGF) Overvalued in 2026?
Based on GuruFocus' analysis, Jinxin Fertility Group stock appears to be undervalued.
The current stock price of $0.29 is trading 32.6% below its estimated GF Value™ of $0.43.
Key valuation signals for JXFGF:
Equity-to-Asset: 0.66 (near median its 10-year median of 0.67)
GF Value™: $0.43 vs. price of $0.29 (32.6% below fair value)
Industry Position: 34.7% above the Healthcare Providers & Services median (#224 of 687)
No single metric tells the full story. See the JXFGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm, through its subsidiary, is engaged in Assisted reproductive services, management services, ambulatory surgery centre facilities services, obstetrics, gynecology & pediatrics medical services, sales of medical consumables and equipment. and ancillary medical services. Geographically, the company generates a majority of its revenue from Greater China, with a small portion of revenue generated from Overseas Business.
86GF Score
Get the complete analysis for JXFGF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JXFGF has been successfully added to your 
